Akèy › Limfòm selil B › Michigan › Ann Arbor
Etid klinik pou Limfòm selil B nan Ann Arbor, MI
5 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Ap rekriteFaz 3
- University of Michigan, Ann Arbor
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
Ap rekriteFaz 1
- University of Michigan Rogel Cancer Center, Ann Arbor
DALY II USA/ MB-CART2019.1 for DLBCL
Ap rekriteFaz 2
- University of Michigan, Ann Arbor
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- C.S. Mott Children's Hospital, Ann Arbor
Etid Limfòm selil B nan lòt vil
- New York City, NY19 etid
- Houston, TX16 etid
- Chicago, IL12 etid
- Nashville, TN11 etid
- Philadelphia, PA11 etid
- Rochester, MN10 etid
- Baldwin Park, CA9 etid
- Milwaukee, WI9 etid
- Cleveland, OH9 etid
- Salt Lake City, UT8 etid
- Boston, MA8 etid
- Columbus, OH7 etid
Lòt etid nan Ann Arbor
- Kansè pwostat27 etid
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil26 etid
- Kansè (tout kalite)25 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Ensifizyans kadyak22 etid
- Leksemi mieloïd egi17 etid
- Maladi kadyovaskilè16 etid
- Kansè pankreyas14 etid
- Melanom12 etid
- Kansè renn (Kasinom selil renn)12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.